U.S. market Open. Closes in 4 hours 47 minutes

SLDB | Solid Biosciences Inc. Stock Financials Income Statements Annual

(Stock Exchange: NASDAQ)
*Sign In to persist settings
Financial Year End2023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-312015-12-31
RevenueN/A8.09M13.62MN/AN/AN/AN/AN/AN/A
Cost of Revenue76.56M2.41M58.74M3.92M2.82MN/AN/AN/AN/A
Gross Profit-76.56M5.69M-45.12M-3.92M-2.82MN/AN/AN/AN/A
Operating Expenses26.59M107.37M85.87M86.46M119.32M75.69M54.86MN/AN/A
Selling, General & Admin27.75M28.95M27.14M21.58M24.58M17.72M14.95M5.46M2.37M
Research & Development76.56M78.42M58.74M64.88M94.74M57.97M39.91M20.12M4.19M
Other Operating ExpensesN/A-381.00K2.00K1.94M515.00K270.00KN/AN/AN/A
Operating Income-104.31M-106.45M-72.25M-88.41M-119.32M-75.69M-54.86M-25.58M-6.56M
Other Expenses / Income8.30M20.47M66.00K116.00K2.10M270.00K1.68M1.80M-100.00K
Before Tax Income-96.02M-85.98M-72.19M-88.29M-117.22M-74.80M-53.18M-23.77M-6.66M
Income Tax ExpensesN/A-20.47M-64.00K1.83M-1.58M889.00KN/AN/AN/A
Net Income-96.02M-65.51M-72.12M-90.12M-115.64M-74.80M-52.12M-21.54M-6.38M
Interest ExpensesN/A-20.47MN/AN/AN/AN/AN/AN/AN/A
Basic Shares Outstanding19.88M8.51M7.12M3.46M2.69M2.22M2.15M14.05M19.23M
Diluted Shares Outstanding19.88M8.51M7.12M3.46M2.69M2.22M2.15M14.05M19.23M
EBITDA-101.73M-107.92M-69.29M-80.60M-116.49M-75.69M-51.67M-25.52M-6.56M
EBITDA Margin0.00%-1,333.38%-508.74%0.00%0.00%0.00%0.00%0.00%0.00%
EBIT-96.02M-106.45M-72.19M-88.29M-117.22M-73.91M-52.12M-21.54M-6.38M
EBIT Margin0.00%-1,315.20%-530.01%0.00%0.00%0.00%0.00%0.00%0.00%
Financial Year End2023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-312015-12-31
An error has occurred. This application may no longer respond until reloaded. Reload 🗙